Private equity firms see several ways to push exits back up to historical norms in 2025 – with or without public listings.

Hexaware's IPO offers growth potential, but investors should consider industry disruption, US economy risks, and expensive ...

Asia’s “nascent capital market” needs a catalyst — but investors shouldn’t be deterred from investing in the region’s private ...

Some IPO prospects are staying private for now to ... high revenue multiples to calculate valuations. Hinge Health, for example, will have to contend with the $6.2 billion valuation it landed ...

Reddit Inc.’s blistering advance since it went public last year has inflated hopes for the social-media platform’s earnings ...

The company, which turns crab shells into sustainable products for a variety of industries, raised a $140 million Series B round this week.

We advise caution on Dr. Martens due to risks and challenges. Read here for DOCMF stock's struggles post-IPO and potential ...

Rapyd is the third Israel fintech unicorn to record a huge drop in valuation in just a few years. Three years after the peak of the high-tech bubble, three of Israel's leading fintech companies - ...

Compared with 2023, Asia's IPO activity declined further in 2024 ... In today's context, examples include U.S. President Donald Trump's threat of tariffs, and Chinese startup DeepSeek's launch ...